YOLFTbeta
Shanghai Fosun Pharmaceutical Group Co Ltd

Shanghai Fosun Pharmaceutical Group Co Ltd

600196 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

22.53CNY-0.28 (-1.23%)

Price History

Full chart

Market Stats

Previous Close22.81
Open22.69
Day Range22.50 – 22.89
52-Week Range20.85 – 30.09
Volume11.22M
Market Cap64.14B
P/E (TTM)18.77
Forward P/E17.76
EPS1.28
Dividend Yield1.62%
Beta0.43
50-Day Avg23.04
200-Day Avg24.71

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEODr. Yi Liu
  • Employees40.68K
  • HeadquartersBuilding A, Shanghai, China, 200233, China
  • Websitehttps://www.fosunpharma.com

Leadership

  • Ms. Xiaohui GuanExecutive Co-Chairman · b. 1971
  • Mr. Yuqing ChenExecutive Chairman · b. 1975
  • Dr. Yi LiuCEO, Chair of Fosun MedTech, Co-Chair of Innovative Medicines Division & Exec Director · b. 1975
  • Mr. Deyong WenExecutive Vice Chairman · b. 1971
  • Ms. Rongli FengExecutive President & Chief Human Resources Officer · b. 1975
  • Ms. Jing LiCo-President and CEO of Mature Products and Manufacturing Business Unit · b. 1972
  • Mr. Wang Xingli M.D., Ph.D.Co-President & CEO of the Innovative Drugs Business Unit · b. 1962
  • Mr. Wenjie ZhangCo-President & Co-CEO of Innovative Medicines Division · b. 1967
  • Mr. Xiang Li DPHILSVP, Co-President & CSO of the Innovative Drugs Business Unit · b. 1966
  • Ms. Jia YanChief Accountant, Co-CFO & Assistant to the President and Employee Director · b. 1982

Financials

Income Statement

Currency: CNY1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue64.65M92.68M190.35M340.39M442.45M566.83M727.84M1.03B2.15B2.41B2.99B4.08B3.69B3.77B3.85B4.56B6.49B7.34B10.00B12.03B12.61B14.63B18.53B24.92B28.59B30.31B39.01B43.95B41.40B41.07B41.50B
Growth (%)-+43.35%+105.38%+78.82%+29.98%+28.11%+28.41%+41.74%+108.84%+11.81%+24.05%+36.59%-9.52%+2.16%+2.04%+18.31%+42.37%+13.19%+36.18%+20.30%+4.85%+16.02%+26.69%+34.45%+14.72%+6.02%+28.72%+12.66%-5.81%-0.80%+1.06%
Cost of Revenue50.11M65.34M116.47M209.32M248.42M307.64M448.86M668.11M1.56B1.65B2.08B2.28B2.69B2.71B2.61B2.98B3.99B4.13B5.57B6.75B6.33B6.75B7.63B10.38B11.56B13.80B20.29B23.26B21.72B21.43B22.39B
Gross Profit14.55M27.34M73.88M131.07M194.03M271.88M278.99M363.55M590.55M773.58M896.17M885.34M999.48M1.06B1.24B1.57B2.49B3.21B4.43B5.28B6.28B7.87B10.91B14.54B17.03B16.51B18.72B20.70B19.68B19.64B19.12B
Gross Margin22.50%29.50%38.81%38.51%43.85%47.97%38.33%35.24%27.41%32.11%29.99%21.69%27.06%28.13%32.20%34.48%38.46%43.78%44.27%43.90%49.82%53.83%58.85%58.33%59.57%54.47%47.98%47.09%47.54%47.83%46.06%
Operating Expense5.86M17.54M24.61M57.47M82.36M140.44M134.92M195.06M265.85M658.94M661.72M548.98M262.80M921.99M1.06B430.41M913.89M2.62B3.35B2.88B2.98B4.48B6.83B11.00B12.54B11.79B12.41B16.04B16.38B15.40B16.59B
Operating Income8.69M9.80M49.27M73.61M111.67M131.44M144.07M168.50M324.70M114.64M234.45M336.36M736.69M139.37M184.53M1.14B1.58B593.54M1.08B2.39B3.30B3.39B4.07B3.54B4.49B4.72B6.30B4.66B3.31B4.25B2.52B
Operating Margin13.44%10.58%25.88%21.62%25.24%23.19%19.79%16.33%15.07%4.76%7.85%8.24%19.95%3.69%4.79%25.04%24.37%8.09%10.78%19.91%26.15%23.20%21.99%14.19%15.72%15.58%16.16%10.59%7.99%10.34%6.08%
EBITDA9.65M13.07M42.33M74.67M120.15M154.06M212.95M248.85M445.10M441.05M458.03M556.34M1.02B1.12B3.53B1.52B2.25B877.75M1.49B1.70B2.05B2.39B3.14B3.55B3.68B4.08B4.18B5.54B3.88B5.51B6.10B
EBITDA Margin14.92%14.10%22.24%21.94%27.16%27.18%29.26%24.12%20.66%18.31%15.33%13.63%27.71%29.62%91.73%33.30%34.70%11.96%14.89%14.17%16.26%16.35%16.92%14.24%12.86%13.47%10.72%12.61%9.38%13.43%14.69%
Net Income5.98M6.38M39.63M63.73M92.16M128.52M135.52M147.21M263.62M215.33M159.03M259.16M625.78M690.86M2.50B863.65M1.17B1.56B1.58B2.11B2.46B2.81B3.12B2.71B3.32B3.66B4.73B3.73B2.39B2.77B3.37B
Net Income Margin9.25%6.88%20.82%18.72%20.83%22.67%18.62%14.27%12.24%8.94%5.32%6.35%16.94%18.31%64.88%18.96%17.97%21.30%15.83%17.57%19.51%19.18%16.86%10.87%11.62%12.09%12.12%8.49%5.76%6.74%8.12%
R&D---------22.32M22.54M28.93M-57.45M-119.86M189.43M369.89M437.61M564.22M670.04M714.75M1.03B1.48B2.04B2.80B3.99B4.30B4.37B3.68B3.56B
R&D as % of Total Revenue---------0.93%0.75%0.71%-1.52%-2.63%2.92%5.04%4.38%4.69%5.31%4.89%5.54%5.94%7.14%9.22%10.23%9.79%10.55%8.96%8.58%
Interest Expense1.48M3.04M3.05M--9.76M23.73M36.17M45.92M37.02M73.59M83.29M130.58M149.59M138.83M175.45M335.68M393.79M397.90M459.01M509.64M511.68M603.75M965.97M1.09B899.09M852.43M992.40M1.36B1.47B1.30B
Interest Expense % of Total Revenue2.29%3.29%1.60%--1.72%3.26%3.51%2.13%1.54%2.46%2.04%3.54%3.96%3.61%3.85%5.18%5.36%3.98%3.82%4.04%3.50%3.26%3.88%3.82%2.97%2.19%2.26%3.29%3.58%3.14%

Balance Sheet

Currency: CNY1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets106.70M111.29M287.13M647.14M858.23M1.57B2.21B3.14B4.22B5.17B5.67B6.63B7.43B7.54B11.53B16.82B22.29B25.51B29.48B35.34B38.20B43.77B61.97B70.55B76.12B83.69B93.29B107.16B113.47B117.46B120.47B
Total Liabilities81.10M79.32M154.46M116.36M201.15M352.61M884.68M1.47B2.20B2.36B2.79B2.99B3.12B3.09B4.58B7.43B10.92B10.20B11.81B16.23B17.53B18.52B32.23B36.96B36.92B37.70B44.92B53.05B56.85B57.53B57.97B
Total Equity25.60M31.98M100.72M519.15M604.50M1.15B1.26B1.41B1.70B2.30B2.39B3.09B3.87B4.01B6.48B8.42B9.77B13.56B15.33B16.67B18.18B22.19B25.33B27.98B31.89B37.00B39.19B44.58B45.68B47.26B48.74B
Cash7.16M6.57M25.31M329.80M170.05M343.42M372.28M344.10M1.24B682.86M752.91M989.22M1.07B1.01B1.30B3.34B2.89B4.97B3.07B3.70B4.03B6.00B7.25B8.55B9.53B9.96B10.31B16.24B13.69B13.52B9.37B
Total Debt35.35M29.50M22.50M30.09M39.60M154.87M652.65M818.09M1.49B1.43B1.77B2.01B2.30B1.68B2.87B4.59B6.10B5.16B5.62B7.81B10.91B11.22B20.29B23.21B21.91B24.01B24.25B30.25B30.28B31.70B36.71B
Net Debt28.19M22.93M-2.81M-299.70M-130.45M-188.55M280.37M473.99M250.84M751.97M1.01B1.02B1.23B677.33M1.57B1.25B3.21B182.97M2.56B4.11B6.88B5.23B13.04B14.66B12.37B14.05B13.94B14.01B16.59B18.17B27.34B

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow66.55M38.20M138.43M68.15M102.47M150.14M205.10M188.35M184.91M131.48M233.04M261.87M203.36M316.65M665.52M1.01B1.20B1.62B2.11B2.58B2.95B3.22B2.58B3.95B4.22B4.36B4.48B6.01B
Investing Cash Flow-99.77M-238.95M-443.64M-487.06M-150.51M162.07M-779.19M-437.73M-335.12M-53.72M56.09M-397.80M-264.30M-1.77B-978.57M-1.80B-2.48B-1.87B-2.45B-10.50B-5.24B-171.96M-4.71B-3.86B-4.06B-4.78B-3.61B-3.22B
Financing Cash Flow337.70M41.00M466.33M454.20M19.90M586.13M14.57M147.78M370.71M143.13M-349.90M400.98M1.82B913.00M2.07B-932.11M1.86B550.72M1.45B9.91B3.14B-1.94B1.47B-831.28M4.43B-1.33B-1.00B-2.97B
Capital Expenditure52.25M77.99M126.63M141.51M139.52M264.05M205.02M222.60M266.61M209.71M210.63M348.07M339.17M796.83M1.16B1.04B1.12B1.24B1.92B2.17B3.17B3.96B4.44B4.97B5.89B5.34B4.41B4.45B
Free Cash Flow14.30M-39.79M11.80M-73.35M-37.05M-113.92M85.20K-34.26M-81.69M-78.23M22.41M-86.20M-135.81M-480.18M-495.08M-28.42M80.78M385.49M188.08M409.61M-224.81M-739.65M-1.86B-1.02B-1.67B-1.92B66.79M1.56B
Dividends Paid9.75M13.36M14.14M78.20M89.81M94.86M149.22M200.04M371.87M237.61M257.93M268.57M297.41M437.31M500.92M804.46M962.65M1.11B1.19B1.43B1.78B818.63M1.00B1.10B1.44B2.46B2.06B844.70M
FCF to OCF21.49%-104.17%8.53%-107.63%-36.15%-75.88%0.04%-18.19%-44.18%-59.50%9.62%-32.92%-66.78%-151.64%-74.39%-2.81%6.73%23.78%8.91%15.87%-7.62%-22.95%-72.00%-25.93%-39.63%-44.06%1.49%25.92%
Dividend Paid to FCF68.13%-33.57%119.78%-106.60%-242.43%-83.27%175148.76%-583.96%-455.20%-303.74%1150.81%-311.57%-218.99%-91.07%-101.18%-2830.45%1191.74%287.76%634.59%349.98%-789.81%-110.68%-53.87%-107.73%-85.89%-127.71%3083.42%54.26%

Earnings

Report DateMar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007May 28, 2008Sep 3, 2008Dec 3, 2008Jun 3, 2009Sep 2, 2009Dec 2, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Mar 27, 2013Apr 25, 2013Aug 26, 2013Oct 30, 2013Mar 24, 2014Apr 29, 2014Aug 26, 2014Oct 28, 2014Mar 20, 2015Apr 28, 2015Aug 26, 2015Oct 29, 2015Mar 29, 2016Apr 28, 2016Aug 23, 2016Oct 28, 2016Mar 28, 2017Apr 27, 2017Aug 29, 2017Oct 30, 2017Mar 26, 2018Apr 27, 2018Aug 27, 2018Oct 29, 2018Mar 25, 2019Apr 29, 2019Aug 26, 2019Oct 29, 2019Mar 30, 2020Apr 29, 2020Aug 25, 2020Oct 29, 2020Mar 29, 2021Apr 26, 2021Aug 23, 2021Oct 26, 2021Mar 22, 2022Apr 26, 2022Aug 29, 2022Oct 30, 2022Mar 27, 2023Apr 28, 2023Aug 29, 2023Oct 30, 2023Mar 26, 2024Apr 29, 2024Aug 27, 2024Oct 29, 2024Mar 26, 2025Apr 29, 2025Aug 26, 2025Sep 30, 2025Mar 24, 2026Apr 28, 2026Aug 25, 2026
EPS Estimate---------------------------------------------0.13-0.140.340.220.280.180.280.250.280.200.350.310.290.310.410.340.320.170.400.320.270.330.350.280.630.190.360.310.440.340.950.470.340.330.430.410.380.380.330.390.410.350.280.300.260.310.280.300.290.330.36
EPS Actual0.000.000.000.010.000.020.000.000.010.010.010.010.010.010.01-0.000.010.010.010.020.020.040.020.100.060.090.030.090.091.010.150.180.120.100.070.130.320.110.050.180.190.210.220.160.310.120.280.180.250.160.230.160.330.190.240.190.370.240.260.310.390.290.280.280.350.140.240.280.310.220.490.300.440.300.460.330.640.420.460.180.420.350.480.370.300.190.040.230.230.290.290.290.350.310.320.330.32
Surprise----------------------------------------------7.69%-28.57%-26.47%-27.27%-17.86%-11.11%17.86%-24.00%-14.29%-5.00%5.71%-22.58%-10.34%0.00%-4.88%-14.71%-12.50%64.71%-12.50%-56.25%-11.11%-15.15%-11.43%-21.43%-22.22%57.89%22.22%-3.23%4.55%-2.94%-32.63%-10.64%35.29%-45.45%-2.33%-14.63%26.32%-2.63%-9.09%-51.28%-90.24%-34.29%-17.86%-3.33%11.54%-6.45%25.00%3.33%10.34%0.00%-11.11%
Timing---------------------------------------------Pre-market-Pre-market-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-After-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap64.14B
Enterprise Value82.23B
Trailing P/E18.77
Forward P/E17.76
Price / Sales1.51
Price / Book1.27
EPS1.28
Book Value18.46
Revenue (TTM)42.59B
Gross Profit (TTM)21.56B
EBITDA5.90B
Profit Margin7.96%
Operating Margin4.87%
Return on Equity6.95%
Return on Assets1.40%
Shares Outstanding2.12B
Shares Float1.63B
Beta0.43
Dividend Yield1.62%
Dividend Rate0.39
Payout Ratio25.00%

Dividends

20231×
0.42Aug 9, 2023
20221×
0.56Jun 16, 2022
20211×
0.43Jul 19, 2021
20201×
0.39Jul 30, 2020
20191×
0.32Aug 2, 2019
20181×
0.38Aug 3, 2018
20171×
0.35Aug 9, 2017
20161×
0.32Jun 23, 2016
20151×
0.28Aug 12, 2015
20141×
0.27Aug 19, 2014
20131×
0.21Aug 19, 2013
20121×
0.10Jun 11, 2012
20111×
0.10Jul 11, 2011
20101×
0.10Jul 26, 2010
20091×
0.07Aug 19, 2009
20081×
0.07Jul 10, 2008
20071×
0.07Jun 8, 2007
20061×
0.17Apr 26, 2006
20051×
0.08Jun 21, 2005
20041×
0.10Jun 24, 2004
20031×
0.04Jun 6, 2003
20021×
0.04Jun 18, 2002
20011×
0.04May 31, 2001

Stock Splits

  • Jul 26, 20103:2
  • Jun 8, 200713:10
  • Jun 24, 20042:1
  • Jun 18, 200213:10
  • Jul 28, 2000541:522
  • Mar 31, 20006:5
  • Feb 2, 19993:2